Effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 6, 2008, Pages 1510-1513

  Tabata, Minoru ^a   Khalpey, Zain ^a   Cohn, Lawrence H ^a   Chen, Fredrick Y ^a   Bolman III, R Morton ^a   Rawn, James D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STROKE; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY DISEASE; FEMALE; HEART DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 57949084424     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.03.061     Document Type: Article

References (27)

1. Liao J.K. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96 suppl (2005) 24F-33F
2. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
4. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335 (1996) 1001-1009
5. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 339 (1998) 1349-1357
6. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
7. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
8. Liem A.H., van Boven A.J., Veeger N.J., et al. Fluvastatin On Risk Diminishment after Acute myocardial infarction study group. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. Eur Heart J 23 (2002) 1893-1896
9. Thompson P.L., Meredith I., Amerena J., Campbell T.J., Sloman J.G., and Harris P.J. Pravastatin in Acute Coronary Treatment (PACT) Investigators. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. Am Heart J 148 (2004) e2
10. Dotani M.I., Elnicki D.M., Jain A.C., and Gibson C.M. Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 86 (2000) 1128-1130
11. Pan W., Pintar T., Anton J., Lee V.V., Vaughn W.K., and Collard C.D. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 11 Suppl. 1 (2004) II45-II49
12. Collard C.D., Body S.C., Shernan S.K., Wang S., and Mangano D.T. Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 132 (2006) 392-400
13. Cepeda M.S., Boston R., Farrar J.T., and Strom B.L. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158 (2003) 280-287
14. D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
15. Hanley J.A., Negassa A., Edwardes M.D., and Forrester J.E. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157 (2003) 364-375
16. Clark L.L., Ikonomidis J.S., Crawford Jr. F.A., et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg 131 (2006) 679-685
17. Li S., Price R., Phiroz D., Swan K., and Crane T.A. Systemic inflammatory response during cardiopulmonary bypass and strategies. J Extra Corpor Technol 37 (2005) 180-188
18. Chello M., Patti G., Candura D., et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 34 (2006) 660-667
19. Chello M., Carassiti M., Agro F., et al. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth (2004) 605-609
20. Liakopoulos O.J., Dorge H., Schmitto J.D., Nagorsnik U., Grabedunkel J., and Schoendube F.A. Effects of preoperative statin therapy on cytokines after cardiac surgery. Thorac Cardiovasc Surg 54 (2006) 250-254
21. Vaughan C.J., and Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30 (1999) 1969-1973
22. Chello M., Goffredo C., Patti G., et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Eur J Cardiothorac Surg 28 (2005) 805-810
23. Osman L., Amrani M., Isley C., Yacoub M.H., and Smolenski R.T. Stimulatory effects of atorvastatin on extracellular nucleotide degradation in human endothelial cells. Nucleosides Nucleotides Nucleic Acids 25 (2006) 1125-1128
24. Aboyans V., Labrousse L., Lacroix P., et al. Predictive factors of stroke in patients undergoing coronary artery bypass grafting: statins are protective. Eur J Cardiothorac Surg 30 (2006) 300-304
25. Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 114 (2006) 1455-1461
26. Wassmann S., Faul A., Hennen B., Scheller B., Bohm M., and Nickenig G. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on coronary endothelial function. Circ Res 93 (2003) e98-e103
27. Correia L.C., Sposito A.C., Lima J.C., et al. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. Am J Cardiol 92 (2003) 298-301